1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 3 results for author "Maryam Maqsood".

$Thumbnail for Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis$

ABCL - 1011

Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis

Maryam Maqsood

Poster Presenter: Maryam Maqsood

$Thumbnail for Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis$

ABCL - 981

Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis

Maryam Maqsood

Poster Presenter: Maryam Maqsood

Authors

Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis

Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis

Efficacy and Safety of Chimeric Antigen Receptor T-cell (CAR-T) Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis